Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction

Skeletal complications of ADT: disease burden and treatment options

(2012) Jacques Planas Morin et al.   ASIAN JOURNAL OF ANDROLOGY

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Wnt/β-Catenin Signaling and Disease

(2012) Hans Clevers et al.   CELL

Metabolic Complications of Androgen Deprivation Therapy for Prostate Cancer

(2012) Philip J. Saylor et al.   JOURNAL OF UROLOGY

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial

(2011) Matthew R Smith et al.   LANCET

Induction of Interleukin-6 Expression by Bone Morphogenetic Protein-6 in Macrophages Requires Both SMAD and p38 Signaling Pathways

(2010) Geun Taek Lee et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase

(2010) H Yamamoto et al.   ONCOGENE

Laminin γ2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells

(2009) Hideki Yamamoto et al.   GASTROENTEROLOGY

Bone morphogenetic protein-6 induces the expression of inducible nitric oxide synthase in macrophages

(2009) Seok J. Kwon et al.   IMMUNOLOGY

Epigenetic-Mediated Dysfunction of the Bone Morphogenetic Protein Pathway Inhibits Differentiation of Glioblastoma-Initiating Cells

(2008) Jeongwu Lee et al.   CANCER CELL

Prostate Cancer Induces Bone Metastasis through Wnt-Induced Bone Morphogenetic Protein-Dependent and Independent Mechanisms

(2008) J. Dai et al.   CANCER RESEARCH